Clinical Obesity
TDR programmes and GLP-1 receptor agonists are modern treatments that can each produce more than 10% average weight loss. Clinical obesity is high BMI accompanied by adiposity-driven disease such as hypertension, type 2 diabetes, MASH, imp…
1 sources - 4 claims
TDR programmes and GLP-1 receptor agonists are modern treatments that can each produce more than 10% average weight loss. Clinical obesity is high BMI accompanied by adiposity-driven disease such as hypertension, type 2 diabetes, MASH, impaired mental health, or sleep apnoea. Severe obesity is defined using BMI thresholds of at least 35 kg/m² for white individuals and at least 32.5 kg/m² for non-white individuals.